Do Zinc Supplements Reduce Mortality in Patients with COVID-19?

Abstract: The University of Toledo Infectious Diseases Abstract, Department of Medicine Research Symposium Translation Journal of Medical Sciences UTJMS 2023 May 5; 11(1):e1-e1 Do Zinc Supplements Reduce Mortality in Patients with COVID-19? A Systematic Review and Meta-Analysis Ziad Abuhelwa, MD1*, Salik Khuder, PhD 1 Division of Internal Medicine, Department of Medicine, The University of Toledo, Toledo, OH 43614 *Corresponding author: Ziad.Abuhelwa@utoledo.edu Published: 05 May 2023 Introduction: Zinc is a trace element that has major role in human immune system. This study aims to assess the clinical benefits of zinc supplements on all-cause mortality in patients with COVID-19. Method: PubMed/MEDLINE, EMBASE, and Cochrane databases were searched for studies that evaluated the clinical efficacy of zinc supplements in patients diagnosed with COVID-19. The outcome was all-cause mortality rate. Pooled relative risk (RR) and corresponding 95% confidence intervals (ICs) were calculated and combined using a random-effects model. Results: A total of 6 studies (3 randomized clinical trials and 3 retrospective observational studies) that included 1,670 patients with COVID-19 (855 received zinc supplements vs. 812 received standard of care without zinc) were included in our systematic review. Our meta-analysis showed that there is statistically significant difference in all-cause mortality rate between the two groups favoring zinc supplements (RR 0.66; 95%CI 0.54 - 0.81; P <0.0001) Conclusion: Our study demonstrated that zinc supplements in addition to standard of care can reduce all-cause mortality in patients with COVID-19. https://dx.doi.org/10.46570/utjms.vol11-2023-749